Boston Scientific Corp
Health Care
Current price
Target price 00%
Ranks rating
76
Position in sub-industry
159 / 663
Position in country
3148 / 14179
Return on Assets, %
4.7
-11.9
Net income margin, %
13.5
-12.5
EBITDA margin, %
24.9
-2.5
Debt to Equity, %
47.2
15
Intangible assets and goodwill, %
58
3.9
Revenue CAGR 3Y, %
12.8
12.6
Total Equity change 1Y, %
9.7
0
Revenue Y, % chg
12.2
4.6
P/E
63.5
28.3
P/BV
5.1
1.7
P/S
7
3.7
EV/S
7.6
3.2
EV/EBITDA
26.6
-0.2
Average Analyst recommendation
Buy
Buy
Average upside forecasts, %
5.7
66.5
Forward P/E
29.1
19.2
Expected dividend per share
0
0
Payout Ratio, %
0
17.3
Competitors
Ranks
-
Dexcom Inc
00%
-
Boston Scientific Corp
00%
-
Intuitive Surgical Inc
00%
-
Stryker Corp
00%
-
Edwards Lifesciences Corp
00%
-
IDEXX Laboratories Inc
00%
-
Resmed Inc
00%
-
Abbott Laboratories
00%
-
GE Healthcare Technologies Inc
00%
-
Becton Dickinson and Co
00%
Ready-made portfolio of the best Russian stocks
- Created by artificial intelligence
- Verified by analysts
- Available even to beginners
Company information
Country
United States of America
Sector
Health Care
Industry group
Health Care Equipment & Services
Industry
Health Care Equipment & Supplies
Sub-sector
Health Care
Capitalization (millions of $)
100055.7
Ticker
BSX.N
ISIN
US1011371077
IPO date
1992-05-19
Availability on Russian exchanges
Yes
Reporting for
2024-02-20
Date fact. publication of reports
2023-12-31
Company Description
Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company offers its products by businesses such Interventional Cardiology, Peripheral Interventions, Cardiac Rhythm Management, Electrophysiology, Endoscopy, Urology and Pelvic Health, Neuromodulation and Specialty Pharmaceuticals. It operates in three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. MedSurg consists of Endoscopy and Urology and Pelvic Health businesses. Rhythm segment consists of Cardiac Rhythm Management, Electrophysiology and Neuromodulation businesses. Its Cardiovascular segment consists of Interventional Cardiology and Peripheral Interventions businesses. Its product offerings include balloon catheters, rotational atherectomy systems, guide wires, guide catheters, embolic protection devices and diagnostic catheters used in percutaneous transluminal coronary angioplasty (PTCA) procedures.
A step towards better analytics
- find the best promotions through the Screener
- keep an eye on stock valuation
- download detailed reports
and much more after free registration
RegistrationMore convenient from your phone? Download: